| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |